NCT00493064View on ClinicalTrials.gov

To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions

Retinal Vein Occlusion

Interventions

DRUG

Nicotinic acid

topical eye drops

DRUG

Prednisolone acetate

topical eye drops

Trial Locations (1)

94301

Palo Alto Medical Foundation Department of Ophthalmology, Palo Alto

All Listed Sponsors

lead

Palo Alto Medical Foundation

OTHER

NCT00493064 - To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions | Biotech Hunter | Biotech Hunter